Details of the Drug

General Information of Drug (ID: DMMEAGO)

Drug Name
BMS-955176
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus-1 infection 1C62 Phase 2 [1]
Cross-matching ID
PubChem CID
60152109
UNII
4CA9IAU7RJ
DrugBank ID
DB15193
TTD ID
D0K5TE
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Human immunodeficiency virus Maturation (HIV Mat) TT5TOX7 NOUNIPROTAC Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT02415595) Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Bristol-Myers Squibb.